Related Experiment Video

Updated: May 20, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Cerebral small vessel disease, cognitive impairment and vascular dementia

C Sierra1

  • 1Hypertension and Vascular Risk Unit, Department of Internal Medicine, Institute of Medicine and DermatologyHospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain. csierra@clinic.ub.es

Panminerva Medica
|July 18, 2012
PubMed

Insights

Vascular risk factors like hypertension significantly contribute to Alzheimer

Area of Science:

  • Neurology
  • Cardiovascular Science
  • Gerontology

Background:

  • Growing evidence links vascular risk factors, including hypertension, diabetes, high cholesterol, and smoking, to Alzheimer's disease.
  • Vascular dementia, traditionally linked to stroke, now appears on a continuum with Alzheimer's, sharing overlapping pathological features.
  • The brain is particularly vulnerable to the damaging effects of high blood pressure.

Purpose of the Study:

  • To explore the intricate relationship between hypertension and cognitive decline, including vascular dementia and Alzheimer's disease.
  • To investigate the role of cerebral small vessel disease and microvascular changes in hypertension-related cognitive impairment.
  • To examine the potential of antihypertensive treatments in preventing cognitive decline and dementia.

Main Methods:

  • Review of accumulating evidence on vascular risk factors and their impact on brain health.
  • Analysis of pathological processes in cerebral small vessel disease and their association with cognitive impairment.
  • Examination of existing data on blood pressure levels and their correlation with cognitive decline and dementia.

Main Results:

  • Hypertension is identified as a major modifiable risk factor for stroke, cerebral small vessel disease, and subsequent vascular dementia.
  • Hypertension can lead to subtle cerebral changes, including arteriolar narrowing and microvascular pathology, contributing to cognitive impairment.
  • Both high and low blood pressure, particularly in the elderly, are associated with cognitive decline and dementia.

Conclusions:

  • Hypertension is a critical factor in the development of vascular dementia and may influence Alzheimer's disease progression.
  • Cerebral small vessel disease, often linked to hypertension, plays a significant role in vascular cognitive impairment.
  • Antihypertensive drug treatment may offer a preventive strategy for cognitive impairment and vascular dementia, although optimal blood pressure targets require further research.

More Related Videos

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...